Scientific Studies
The brochure includes the synopsis of our 26 published clinicals and 24 ongoing clinicals.
Shri Kartikeya Pharma
-
Country/Region:India
-
On CPHI since:2022
-
Certificates:2
-
Employees:500 - 999
Other Content from Shri Kartikeya Pharma (2)
-
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pertaining to regulations, quality control, supply chain disruptions, and sustainability efforts.
-
Report Trend Report - Pharma's Next Big Opportunity: Exploring the Potential of Herbal Medicines in Modern Healthcare
Steeped in centuries of tradition, natural extract products and herbal treatments still face numerous challenges when entering the commercial market. Inconsistent regulations, quality control oversight, and sustainable sourcing and procurement are among some of the top concerns for the pharmaceutical and nutraceutical industries. Despite these hurdles, natural extract products are shaping up to be pharma’s next big opportunity for investment as consumers look to take control of their own health with traditional herbal ingredients. Ashwagandha, in particular, is a trending extract boasting several health benefits against stress, sexual dysfunction, and increasing endurance. Our latest Trend Report, created in partnership with KSM-66 Ashwagandha, explores the potential of Ashwagandha root extract in consumer healthcare markets, and how the pharmaceutical and nutraceutical industries can work together to overcome obstacles within the Ashwagandha supply and value chain. Register to download your free Trend Report now.